Featured Research

from universities, journals, and other organizations

Medication education key to successful adherence in patients with diabetes

Date:
February 9, 2011
Source:
University of California - San Diego
Summary:
Researchers say that medication education is a key factor in helping patients with diabetes better stick to their drug treatments plans. The study points to the need for pharmacists and other health care providers to assess reasons why some patients don't adhere to their medication plans, and to provide counseling opportunities to help them.

Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego say that medication education is a key factor in helping patients with diabetes better stick to their drug treatments plans. The study, currently on line in the February issue of the journal Annals of Pharmacotherapy, points to the need for pharmacists and other health care providers to assess reasons why some patients don't adhere to their medication plans, and to provide counseling opportunities to help them.

"Counseling can be more effective if pharmacists recognize that individual patients are each motivated to adhere to their drug regimens in different ways," said Candis M. Morello, PharmD, associate professor of clinical pharmacy at UCSD's Skaggs School of Pharmacy. "By understanding these differences, and knowing what actually works for individual patients, pharmacists can provide a very important service."

Diabetes is a complex disorder, typically requiring multiple medications to achieve control of the patient's blood sugar levels. Medication adherence -taking medications as instructed at the right time of day, frequency and dosage -- is a significant factor for a patient's successful management of their disease. Therefore, knowing which methods diabetes patients and caregivers report help for improving adherence can provides valuable knowledge to make counseling opportunities more effective.

Morello and colleagues surveyed more than 1200 individuals over age 18, most of whom (about 75%) had type 2 diabetes. Nearly half of this number took only oral medications, and the vast majority (86.8%) of the patients with diabetes reported taking medications two or more times per day.

Their goal was to determine methods that patients and their caregivers have used to improve medication adherence, assess the perceived helpfulness of such methods and identify motivating factors or medication characteristics that might help patients stick to their regimen.

Taking medications as part of a daily routine and utilizing pill boxes were the most frequently reported helpful methods to improve adherence. The three most motivating factors that patients identified were their knowledge that diabetes medications work effectively to lower blood glucose, understanding how they could manage side effects of their medications and a better understanding of the drugs' benefits.

Conversely, non-adherence involved not only a patient's forgetfulness, but also such factors as inability to afford a prescription or adverse reactions to a drug such as weight gain or nausea. As a result, health care providers might deem such regimens unsuccessful and prescribe even more or different drugs.

"To empower patients to overcome medication adherence barriers, we conclude that pharmacists are well-positioned to provide more proactive and thorough counseling sessions to include education of how diabetes drugs work and why they are so important," said Morello. She added that while seemingly simple tools such as using a 7-day pill box may improve a patient's adherence, improvement is often very patient-specific.

"Pharmacists should incorporate an assessment of individual variances into their counseling sessions…and patients should know that their pharmacist is an excellent resource for medication education and advice."


Story Source:

The above story is based on materials provided by University of California - San Diego. Note: Materials may be edited for content and length.


Journal Reference:

  1. C. M. Morello, M. Chynoweth, H. Kim, R. F. Singh, J. D. Hirsch. Strategies to Improve Medication Adherence Reported by Diabetes Patients and Caregivers: Results of a Taking Control of Your Diabetes Survey (February). Annals of Pharmacotherapy, 2011; DOI: 10.1345/aph.1P322

Cite This Page:

University of California - San Diego. "Medication education key to successful adherence in patients with diabetes." ScienceDaily. ScienceDaily, 9 February 2011. <www.sciencedaily.com/releases/2011/02/110209091956.htm>.
University of California - San Diego. (2011, February 9). Medication education key to successful adherence in patients with diabetes. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/02/110209091956.htm
University of California - San Diego. "Medication education key to successful adherence in patients with diabetes." ScienceDaily. www.sciencedaily.com/releases/2011/02/110209091956.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins